Test description
Fetal Rhesus D screening can determine the RhD status of the fetus in RhD-negative mothers who do not have anti-D alloantibodies. If the fetus is also RhD negative, prophylactic anti-D immunoglobulin is not required—avoiding unnecessary treatment that is otherwise routinely given throughout pregnancy.
Test information
Fetal Rhesus D Screening
To determine fetal RhD status where the mother is RhD negative and not alloimmunised.
RHD
Real-time PCR
1 – 2 weeks
73420, conditions apply
If not MBS eligible, please contact 1800 822 999 for details
Dedicated Fetal RhD Screening test form
Blood
10mL Streck tube
Test is recommended to be performed after 18 weeks gestation but can be performed from 11 weeks. A re-test will be required if Fetal RhD result is negative before 18 weeks.